Mention is made that BARDA is still under discussion. That is a good indicator as to likely outcomes. BARDA has a $415M/US annual budget and I am guessing the 2013 allocation has been made. Most contracts are let in the spring(northern hemisphere) so that fits with 1st qtr 2014 as mentioned in annual report.
http://www.genomeweb.com/congress-passes-pandemic-act-extending-funding-project-bioshield-and-barda
"The new act authorizes $415 million per year to fund BARDA between 2014 and 2018, the same annual rate as it received this year. The total cost of BARDA over the next five years would be around $1.6 billion, the CBO estimated."
- Forums
- ASX - By Stock
- CZD
- Ann: Full Year Statutory Accounts
Ann: Full Year Statutory Accounts , page-13
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CZD (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online